Approvals/CIMA-AEMPS/NASACORT 55 microgramos/dosis, SUSPENSION PARA PULVERIZACION NASAL

Approved

STANDARD

NASACORT 55 microgramos/dosis, SUSPENSION PARA PULVERIZACION NASAL

Opella Healthcare France S.A.S.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 180d6ad4b97fbcc4
Drug Cima Aemps Name: NASACORT 55 microgramos/dosis, SUSPENSION PARA PULVERIZACION NASAL
Register Number: 3400934292293
Holder Company Name: Opella Healthcare France S.A.S.
Marketing Company Name: Difarmed S.L.U.
Authorization Date: 2022-01-21
Dosage Form: SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose: 55µg
Route Of Administration: VÍA NASAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Opella Healthcare France S.A.S.

TRIAMCINOLONA ACETONIDO

55 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 21, 2022

Approval ID

180d6ad4b97fbcc4

Type

Standard